Blood-based test for early diagnosis of head and neck cancer
Part of Cancer clinical trials.
This trial studies a liquid (blood) biopsy test to help identify squamous cell carcinoma in the head and neck area earlier. You may be able to help by providing additional sample(s) as part of a routine neck-lump clinic visit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be referred to the neck lump clinic for an ultrasound-guided fine needle biopsy (USFNA)
- Have a neck lump being evaluated in that clinic (not solely a different condition)
- During the ultrasound-guided biopsy, you must not be found to have a lump that is only in the thyroid gland
- Be able and willing to give informed consent for collecting biological samples
- Be well enough to safely take part in the sample collection during your clinic visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific genetic “methylation” patterns in people with head and neck squamous cell carcinoma. The results may help doctors understand the disease better and identify who may benefit from future treatments.
This trial is for people with head and neck cancer that has not spread to distant parts of the body. It is a non-treatment study that will look at the molecular features of your tumor from a biopsy sample to help guide future treatment decisions.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
This trial tests whether a special ultrasound test using “microbubbles” can help doctors find lymph nodes that may contain cancer in people with head and neck squamous cell carcinoma. If the test finds suspicious nodes, it may guide where to do a biopsy during planned neck surgery.
This study looks for early “biomarkers” (signals in blood or tissue) to see how well head and neck cancer treatments are working over time. It may help doctors adjust treatment sooner based on those early signals.
This trial is testing a new blood test (called a liquid biopsy) to better understand and predict the course of head and neck cancers that have come back or spread. If you join, researchers will use a special chip to look at your immune cells and tumor cells in your blood.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.